GAB2 and hepatocellular carcinoma: Our study demonstrated that miR-181a and miR-9 target Gab2 and inhibit the proliferation and migration of HCC cells, not only identifying a new protein whose expression is targeted by miR-181a and miR-9, but also providing a new approach to inhibit Gab2 protein expression.